Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content



Early Release

  • Addressing a Yellow Fever Vaccine Shortage — United States, 2016–2017

    	The figure above is a photograph showing an open notebook with the word “Yellow Fever” written on one of the pages. The notebook is flanked by a stethoscope, eyeglasses, and pills. April 28, 2017
    Recent manufacturing problems resulted in a shortage of YF-VAX, the only yellow fever vaccine licensed by the United States. This shortage is expected to lead to a complete depletion of yellow fever vaccine available for the immunization of U.S. travelers by mid-2017. CDC and manufacturer Sanofi Pasteur are working to assure a continuous yellow fever vaccine supply in the U.S. after the anticipated complete depletion of YF-VAX.

Current Weekly


Surveillance Summaries

  • Diabetes Self-Management Education Programs in Nonmetropolitan Counties — United States, 2016

    April 28, 2017 
    Diabetes self-management education (DSME) is a clinical practice intended to improve preventive practices and behaviors with a focus on decision-making, problem-solving, and self-care. The distribution and correlates of established DSME programs in nonmetropolitan counties across the United States have not been previously described, nor have the characteristics of the nonmetropolitan counties with DSME programs. This report describes the distribution of established DSME programs in rural counties in the United States and differences in county-level characteristics of those counties with and without a DSME program.

Recommendations and Reports

  • Community Mitigation Guidelines to Prevent Pandemic Influenza — United States, 2017

    April 21, 2017
    Nonpharmaceutical interventions are strategies for disease, injury, and exposure control. They include actions that persons and communities can take to help slow the spread of respiratory viruses (e.g., seasonal and pandemic influenza viruses). These 2017 guidelines provide evidence-based recommendations on the use of NPIs in mitigating the effects of pandemic influenza. These guidelines update and expand the 2007 strategy.

Notifiable Diseases

  • Summary of Notifiable Infectious Diseases and Conditions — United States, 2014

    October 14, 2016
    Health-care providers in the United States are required to report certain infectious diseases to a specified state or local authority. A disease is designated as notifiable if timely information about individual cases is considered necessary for prevention and control of the disease. Each year, CDC publishes a summary of the cases of notifiable disease reported for the most recent year for which data is available. This report presents a summary of notifiable diseases for 2014.

  • Summary of Notifiable Noninfectious Conditions and Disease Outbreaks

    October 14, 2016
    The 2016 Summary of Notifiable Noninfectious Conditions and Disease Outbreaks — United States contains official statistics for the occurrence of nationally notifiable noninfectious conditions and disease outbreaks and is published for the second time in the same volume of MMWR as the annual Summary of Notifiable Infectious Diseases and Conditions. The summary includes seven chapters addressing the following subjects: acute pesticide-related illness and injury arising from occupational exposure, acute nonoccupational pesticide-related illness and injury, cancer, elevated blood lead levels among children, elevated blood lead levels among adults, silicosis, and foodborne and waterborne disease outbreaks. CDC’s Center for Surveillance, Epidemiology, and Laboratory Services (CSELS) coordinated the development and publication of this annual summary.